NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/10/2022
Voltar para busca
Dado oficial do USPTO
MEDICAGO UNLEASH THE POWER OF PLANTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MEDICAGO UNLEASH THE POWER OF PLANTS
ST13
US500000090620821Classe
5, 40, 42, 44
Pedido
90620821
Registro
6868840
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
11/10/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42, 44
Data de depósito
02/04/2021
Data de registro
11/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/10/2022
Última transação
11/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Québec (Québec), CA
Examinador
DAVIS, TRENTON
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Medicago Inc.
Representantes
Benjamin M. Cantor CANTOR COLBURN LLP
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medicinal preparations and substanceshuman vaccinestherapeutic proteins and antibodies for the treatment of infectious diseaseschronic diseases and cancer
Classe 40
Manufacture of pharmaceuticalspharmaceutical ingredientshuman vaccinestherapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticalspharmaceutical ingredientshuman vaccinestherapeutic proteins and antibodies
Classe 42
Research and development in the field of human vaccinesrecombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccinestherapeutic proteins and antibodies; product research and development and scientific researchall in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticalspharmaceutical ingredientshuman vaccinestherapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information servicesproviding medical research information to physicianshealthcare professionals and patients on the topics of diagnosticprophylactic and therapeutic properties of vaccinesrecombinant proteins and antibodies; On-line information servicesproviding medical research information to physicianshealthcare professionals and patients on the topics of diagnosticprophylactic and therapeutic properties of vaccinesrecombinant proteins and antibodies
Classe 44
Medical information servicesproviding medical information to physicianshealthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information servicesproviding medical information to physicianshealthcare professionals and patients on the topics of diagnosticprophylactic and therapeutic properties of vaccinesrecombinant proteins and antibodies; On-line information servicesproviding medical information to physicianshealthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information servicesproviding medical information to physicianshealthcare professionals and patients on the topics of diagnosticprophylactic and therapeutic properties of vaccinesrecombinant proteins and antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/07/2022
PUBO
PUBLISHED FOR OPPOSITION
26/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
22/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
22/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2022
ALIE
ASSIGNED TO LIE
02/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/11/2021
GNRT
NON-FINAL ACTION E-MAILED
26/11/2021
CNRT
NON-FINAL ACTION WRITTEN
26/11/2021
DOCK
ASSIGNED TO EXAMINER
17/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2021
NWAP
NEW APPLICATION ENTERED
06/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDICAGO UNLEASH THE POWER OF PLANTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.